{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T11:12:11Z","timestamp":1772881931577,"version":"3.50.1"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Food and Chemical Toxicology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/j.fct.2023.113708","type":"journal-article","created":{"date-parts":[[2023,3,7]],"date-time":"2023-03-07T00:56:41Z","timestamp":1678150601000},"page":"113708","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"special_numbering":"C","title":["An in vitro evaluation of e-vapor products: The contributions of chemical adulteration, concentration, and device power"],"prefix":"10.1016","volume":"175","author":[{"given":"Stephanie","family":"Johne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"van der Toorn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9270-124X","authenticated-orcid":false,"given":"Anita R.","family":"Iskandar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoaib","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura O.","family":"Torres","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Hoeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5324-359X","authenticated-orcid":false,"given":"Manuel C.","family":"Peitsch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.fct.2023.113708_bib1","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s12944-020-01278-8","volume":"19","author":"Agudelo","year":"2020","journal-title":"Alveolar lipids in pulmonary disease. A review. Lipids Health Dis"},{"issue":"2","key":"10.1016\/j.fct.2023.113708_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1021\/acs.chemrestox.9b00470","article-title":"Selected harmful and potentially harmful constituents levels in commercial e-cigarettes","volume":"33","author":"Belushkin","year":"2020","journal-title":"Chem. Res. Toxicol."},{"issue":"12","key":"10.1016\/j.fct.2023.113708_bib3","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJMc2000231","article-title":"An animal model of inhaled vitamin E acetate and EVALI-like lung injury","volume":"382","author":"Bhat","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"12","key":"10.1016\/j.fct.2023.113708_bib4","first-page":"e6350","article-title":"Vitamin E acetate as a plausible cause of acute vaping-related illness","volume":"11","author":"Boudi","year":"2019","journal-title":"Cureus"},{"issue":"3","key":"10.1016\/j.fct.2023.113708_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0265365","article-title":"Temperature dependence of emission product distribution from vaping of vitamin E acetate","volume":"17","author":"Canchola","year":"2022","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.fct.2023.113708_bib6","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1021\/acs.chemrestox.1c00309","article-title":"formation of redox-active duroquinone from vaping of vitamin E acetate contributes to oxidative lung injury","volume":"35","author":"Canchola","year":"2022","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.fct.2023.113708_bib7","series-title":"Outbreak of Lung Injury Associated with the Use of E-Cigarette, or Vaping","year":"2020"},{"key":"10.1016\/j.fct.2023.113708_bib8","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.3389\/fphar.2019.01619","article-title":"Pulmonary toxicity and the pathophysiology of electronic cigarette, or vaping product, use associated lung injury","volume":"10","author":"Chand","year":"2019","journal-title":"Front. Pharmacol."},{"issue":"7","key":"10.1016\/j.fct.2023.113708_bib9","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/j.amjmed.2019.10.032","article-title":"Cannabinoid oil vaping-associated lung injury and its radiographic appearance","volume":"133","author":"Conuel","year":"2020","journal-title":"Am. J. Med."},{"key":"10.1016\/j.fct.2023.113708_bib10","series-title":"Coresta Recommended Method No 81. Routine Analytical Machine for E-Cigarette Aerosol Generation and Collection - Definitions and Standard Conditions","year":"2015"},{"key":"10.1016\/j.fct.2023.113708_bib11","article-title":"Vaping-induced lung injury: a case of lipoid pneumonia associated with E-cigarettes containing cannabis","volume":"2020","author":"Gay","year":"2020","journal-title":"Case Rep Pulmonol"},{"issue":"8","key":"10.1016\/j.fct.2023.113708_bib12","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1164\/rccm.202009-3507LE","article-title":"Lipid-laden macrophages are not unique to patients with E-cigarette or vaping product use-associated lung injury","volume":"203","author":"Ghosh","year":"2021","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.fct.2023.113708_bib13","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.yrtph.2015.12.019","article-title":"Effect of variable power levels on the yield of total aerosol mass and formation of aldehydes in e-cigarette aerosols","volume":"75","author":"Gillman","year":"2016","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"10.1016\/j.fct.2023.113708_bib14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.toxlet.2020.11.006","article-title":"Comparison of the biological impact of aerosol of e-vapor device with MESH(R) technology and cigarette smoke on human bronchial and alveolar cultures","volume":"337","author":"Giralt","year":"2021","journal-title":"Toxicol. Lett."},{"issue":"3","key":"10.1016\/j.fct.2023.113708_bib15","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.amepre.2016.10.017","article-title":"Trends in E-cigarette awareness and perceived harmfulness in the U.S","volume":"52","author":"Huerta","year":"2017","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.fct.2023.113708_bib16","first-page":"1","article-title":"Iarc working Group on the evaluation of carcinogenic risks to humans","volume":"88","year":"2006","journal-title":"Formaldehyde, 2-butoxyethanol and 1-tert-butoxypropan-2-ol. IARC Monogr Eval Carcinog Risks Hum"},{"issue":"6","key":"10.1016\/j.fct.2023.113708_bib17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.3109\/15376516.2016.1170251","article-title":"A framework for in vitro systems toxicology assessment of e-liquids","volume":"26","author":"Iskandar","year":"2016","journal-title":"Toxicol. Mech. Methods"},{"issue":"1","key":"10.1016\/j.fct.2023.113708_bib18","doi-asserted-by":"crossref","first-page":"23","DOI":"10.14573\/altex.1605041","article-title":"3-D nasal cultures: systems toxicological assessment of a candidate modified-risk tobacco product","volume":"34","author":"Iskandar","year":"2017","journal-title":"ALTEX"},{"issue":"8","key":"10.1016\/j.fct.2023.113708_bib19","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1021\/acs.chemrestox.0c00174","article-title":"Chemical and toxicological characterization of vaping emission products from commonly used vape juice diluents","volume":"33","author":"Jiang","year":"2020","journal-title":"Chem. Res. Toxicol."},{"issue":"3","key":"10.1016\/j.fct.2023.113708_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.31887\/DCNS.2017.19.3\/glafaye","article-title":"Cannabis, cannabinoids, and health","volume":"19","author":"Lafaye","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"issue":"10","key":"10.1016\/j.fct.2023.113708_bib21","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1056\/NEJMoa1911614","article-title":"Pulmonary illness related to E-cigarette use in Illinois and Wisconsin - final report","volume":"382","author":"Layden","year":"2020","journal-title":"N. Engl. J. Med."},{"issue":"1","key":"10.1016\/j.fct.2023.113708_bib22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s13065-014-0062-3","article-title":"Characterization of the Vitrocell(R) 24\/48 in vitro aerosol exposure system using mainstream cigarette smoke","volume":"8","author":"Majeed","year":"2014","journal-title":"Chem. Cent. J."},{"issue":"1","key":"10.1016\/j.fct.2023.113708_bib23","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1186\/s12931-021-01737-5","article-title":"An updated overview of e-cigarette impact on human health","volume":"22","author":"Marques","year":"2021","journal-title":"Respir. Res."},{"issue":"6","key":"10.1016\/j.fct.2023.113708_bib24","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1165\/rcmb.2020-0209OC","article-title":"Dose-dependent pulmonary toxicity of aerosolized vitamin E acetate","volume":"63","author":"Matsumoto","year":"2020","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.fct.2023.113708_bib25","series-title":"E-Cigarettes: an Evidence Update A Report Commissioned by Public Health England","author":"McNeill","year":"2005"},{"issue":"1","key":"10.1016\/j.fct.2023.113708_bib26","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-46387-2","article-title":"The effect of electronic cigarette user modifications and E-liquid adulteration on the particle size profile of an aerosolized product","volume":"9","author":"Mulder","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.fct.2023.113708_bib27","series-title":"Rev. Formaldehyde Assess. National Toxicol. Prog. 12th Report Carcinogens","article-title":"On earth and life studies board on environmental studies and toxicology","year":"2014"},{"issue":"3","key":"10.1016\/j.fct.2023.113708_bib28","article-title":"Vaping-associated lung injury: a review","volume":"58","author":"O'Callaghan","year":"2022","journal-title":"Medicina (Kaunas)"},{"issue":"Pt 1","key":"10.1016\/j.fct.2023.113708_bib29","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.fct.2017.09.001","article-title":"Toxicity of the main electronic cigarette components, propylene glycol, glycerin, and nicotine, in Sprague-Dawley rats in a 90-day OECD inhalation study complemented by molecular endpoints","volume":"109","author":"Phillips","year":"2017","journal-title":"Food Chem. Toxicol."},{"issue":"1","key":"10.1016\/j.fct.2023.113708_bib30","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1186\/s12889-020-09572-x","article-title":"E-cigarettes use in the United States: reasons for use, perceptions, and effects on health","volume":"20","author":"Sapru","year":"2020","journal-title":"BMC Publ. Health"},{"issue":"5","key":"10.1016\/j.fct.2023.113708_bib31","doi-asserted-by":"crossref","first-page":"L1079","DOI":"10.1152\/ajplung.00484.2001","article-title":"Altered fatty acid composition of lung surfactant phospholipids in interstitial lung disease","volume":"283","author":"Schmidt","year":"2002","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"issue":"1","key":"10.1016\/j.fct.2023.113708_bib32","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1080\/08958378.2020.1867260","article-title":"Phytol, not propylene glycol, causes severe pulmonary injury after inhalation dosing in Sprague-Dawley rats","volume":"33","author":"Schwotzer","year":"2021","journal-title":"Inhal. Toxicol."},{"issue":"8","key":"10.1016\/j.fct.2023.113708_bib33","doi-asserted-by":"crossref","first-page":"3587","DOI":"10.7314\/APJCP.2015.16.8.3587","article-title":"Cigarette alternatives: are they safe?","volume":"16","author":"Shantakumari","year":"2015","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"key":"10.1016\/j.fct.2023.113708_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.102982","article-title":"Lipid laden macrophages and electronic cigarettes in healthy adults","volume":"60","author":"Shields","year":"2020","journal-title":"EBioMedicine"},{"issue":"9","key":"10.1016\/j.fct.2023.113708_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph15091853","article-title":"Influence of coil power ranges on the E-liquid consumption in vaping devices","volume":"15","author":"Soulet","year":"2018","journal-title":"Int. J. Environ. Res. Publ. Health"},{"issue":"3","key":"10.1016\/j.fct.2023.113708_bib36","doi-asserted-by":"crossref","first-page":"H604","DOI":"10.1152\/ajpheart.00613.2019","article-title":"A 6-month systems toxicology inhalation study in ApoE(-\/-) mice demonstrates reduced cardiovascular effects of E-vapor aerosols compared with cigarette smoke","volume":"318","author":"Szostak","year":"2020","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.fct.2023.113708_bib37","series-title":"Directive 2014\/40\/EU. 2014 (Updated April 29, 2014)","year":"2014"},{"key":"10.1016\/j.fct.2023.113708_bib38","year":"1981","journal-title":"Health Hazard Eval. report"},{"key":"10.1016\/j.fct.2023.113708_bib39","series-title":"IRIS Toxicological Review of Acrolein","year":"2003"},{"key":"10.1016\/j.fct.2023.113708_bib40","doi-asserted-by":"crossref","DOI":"10.1038\/srep25599","article-title":"Drug vaping applied to cannabis: is \"Cannavaping\" a therapeutic alternative to marijuana?","volume":"6","author":"Varlet","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.fct.2023.113708_bib41","series-title":"Over 1 Year Later: Smokers' EVALI Awareness, Knowledge and Perceived Impact on E-Cigarette Interest","author":"Wackowski","year":"2022"},{"key":"10.1016\/j.fct.2023.113708_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.tiv.2020.104866","article-title":"A comparative in vitro toxicity assessment of electronic vaping product e-liquids and aerosols with tobacco cigarette smoke","volume":"66","author":"Wieczorek","year":"2020","journal-title":"Toxicol. Vitro"}],"container-title":["Food and Chemical Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691523001102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0278691523001102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,8]],"date-time":"2025-01-08T14:07:08Z","timestamp":1736345228000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0278691523001102"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5]]},"references-count":42,"alternative-id":["S0278691523001102"],"URL":"https:\/\/doi.org\/10.1016\/j.fct.2023.113708","relation":{},"ISSN":["0278-6915"],"issn-type":[{"value":"0278-6915","type":"print"}],"subject":[],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An in vitro evaluation of e-vapor products: The contributions of chemical adulteration, concentration, and device power","name":"articletitle","label":"Article Title"},{"value":"Food and Chemical Toxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.fct.2023.113708","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113708"}}